Empowering leaders in regulated scientific sectors to engage with impact | Launching an app for HCPs to track and grow their impact online: https://xitter.cf/t.co/hcbp3DIEyF
UK & wherever
Joined April 2009
- Tweets6.1K
- Following3.1K
- Followers3.6K
- Likes1.6K
Daniel Ghinn retweeted
My most important tweet this year?
Dr Pasquale : your chance of being born outside Africa or Asia is 15% , yet all the representation in trials is from countries outside Africa and Asia, the global pharma and device exclude them from trials! #ESCCongress
I promised yesterday to show you a deep dive into a Digital Opinion Leader profile with LIVE updates today, so I'm keeping that promise!
Here's a look at our #HCM DOL Finder LIVE we're testing at #ESCCongress, which has been capturing excitement today around some key trials being presented.
You'll see the impact that physicians like @MasriAhmadMD , @AndrewJSauer and @drbennisahmed are having in sharing their immersion reflections on new data presented today.
These live updates take the DOL Finder platform to a new level - you no longer need to wait for the next data refresh but can immediately see how doctors are reacting. During medical congress, that can make all the difference to the in-person conversations you have. – at Munich, Germany
Cardiologists and other HCPs are posting their reactions to new data and ideas at #ESCCongress, and the @CREATION team is here tracking whose posts are making a big impact in scientific learning.
If you're posting your ideas about the science you're seeing, come find me and I'll show you an analysis of your own peer engagement and impact in #CVRM indications
At the end of day 1 at #ESCCongress, here's a quick look at the world's most impactful HCPs who have been engaged in the #CVRM digital conversation.
Tomorrow I'll show you what we discover when we dive into one of those profiles.
Top HCPs ranked by global impact so far:
@IhabFathiSulima
@HanCardiomd
@drbennisahmed
@AnastasiaSMihai
@drahmedmohsen85
@Hragy
@Ed_Alania
@Drmahmoudhashe1
@mmamas1973
NB rankings are for overall impact in the scientific digital conversation, not simply volume of posts, measured over the past 12 months of CVRM related digital conversation.
Source: @CREATION DOL Finder LIVE
Daniel Ghinn retweeted
There is intresting live debate going on X amongst people whom I admire ( on X and in real world both ) @oncology_bg @Dr_R_Kurzrock @dr_yakupergun
ORR Vs OS
I could not resist the temptation to make this infographic to show both sides on 1 page for benifit of audience on X .
Research shows the most peer-trusted healthcare professional voices shaping NSCLC scientific learning online during the last three years of ASCO.
@CREATION's unique HCP Peer Impact metric, an algorithm based on how often other HCPs mention a particular HCP within a specific conversation (in this case, posts about lung cancer during ASCO medical congress), is a powerful way to identify which oncologists or other HCPs are most trusted by their online peers.
You'll notice that the most peer-trusted HCPs are not necessarily the noisiest or most-prolific posters, but they certainly play their part.
Ones to watch for #ASCO26:
#1 @StephenVLiu
#2 @HHorinouchi
#3 @CharuAggarwalMD
#4 @RManochakian
#5 @DrJNaidoo
#ASCO23 #ASCO24 #ASCO25 #ASCO26
Do not be misled: #Deepfakes and #misinformation are a threat to patient safety.
Yes, you heard that correctly: deepfaking Digital Opinion Leaders is a real thing, and a real threat.
As we head towards #SABCS25 #SABCS2025, here's our trailer for my incredible conversation with the inspiring @drteplinsky - breast cancer advocate and Digital Opinion Leader.
Coming soon on the Better Listening for Better Health podcast creation.co/podcast
...it's been a long time coming but I'm so glad to start releasing my latest conversations with the HCPs and scientists shaping healthcare!
"Editors and publishers cannot fall back upon the convenient theory of irresponsibility as to advertisements [containing medical misinformation]... They are parties in the transaction and share the profits of this deception practised upon the ignorance and credulousness of the masses they profess to educate and protect."
Boston Medical and Surgical Journal, 1866
The @RoySocMed library is a nice spot in Central London to get some work done in between meetings. I could spend days here - today I enjoyed browsing a few ancient medical journals, with articles from more than 150 years ago describing the latest medical science in the 1800s.
One thing that struck me: doctors tackling medical misinformation in popular media is nothing new!
Here's to all the healthcare professionals today who work tirelessly to combat misinformation on social media.
"Editors and publishers cannot fall back upon the convenient theory of irresponsibility as to advertisements [containing medical misinformation]... They are parties in the transaction and share the profits of this deception practised upon the ignorance and credulousness of the masses they profess to educate and protect."
Boston Medical and Surgical Journal, 1866
Daniel Ghinn retweeted
Publications such as these were significantly amplified by HCPs at #ESCCongress.
HCPs like @DrPascalMeier and @Drroxmehran who referenced the #AQUATIC @NEJM publication also interpreted the data in real-time, helping peers stay informed of the latest data and recommendations.
Daniel Ghinn retweeted
We tracked the most-shared journals by HCPs online on day 3 of #ESCCongress.
The #AQUATIC publication in @NEJM drove HCP discussions discouraging the use of aspirin in patients with chronic coronary syndrome who were already receiving oral anticoagulation.
🧵 1/3
Here's the TL;DR:
@Bayer + @Merck's VICTOR trial was most-discussed by HCPs at #ESCCongress on Saturday, despite not meeting primary endpoint.
#2: BMBF's DIGIT-HF
#3: @TIMIStudyGroup's DAPA-ACT HF-TIMI 68 (with @AstraZeneca)
#4: @Bayer + @Merck's VICTORIA
#5 @Rigshospitalet's POTCAST
#6: Pr Eva Prescott's BETAMI–DANBLOCK
#7: @BMSNews' ODYSSEY-HCM
#8: @AstraZeneca's BaxHTN
#9: @Pfizer + @TorBiering's DAN-RSV
#10: @Cytokinetics' MAPLE-HCM
Day 2 of #ESCCongress flew by!
We tracked the most mentioned trials discussed by HCPs online on day 2 of ESC. The VICTOR trial, sponsored by @Merck, generated the most conversation despite not meeting its primary end-point.
🧵1/3
Daniel Ghinn retweeted
Got your coffee? Pick up a waffle at @CREATION #ESCCongress stand E555 when you complete a quick challenge!
#ESCWaffles
ICYMI here's @CREATION's quick summary of the trials most-discussed by HCPs online at #ESCCongress on day 2 (Saturday).
@CREATION's analysis cuts out the noise, and distils only the HCP voice on #socialmedia.
Read the thread for more info...
Day 2 of #ESCCongress flew by!
We tracked the most mentioned trials discussed by HCPs online on day 2 of ESC. The VICTOR trial, sponsored by @Merck, generated the most conversation despite not meeting its primary end-point.
🧵1/3
We ranked >11,000 HCPs who talk about #HeartFailure on X.
See where you rank, at #ESCCongress stand E555 with @CREATION.
Currently the world's most peer-impactful HCPs in HF?
#1 @AndrewJSauer
#2 @HanCardioMD
#3 @gcfmd
#4 @mvaduganathan
#5 @GiuseppeGalati_
...closely followed by:
#6 @hvanspall
#7 @DrMarthaGulati
#8 @SeguraCardio
#9 @DrRajivsankar
#10 @iamritu
Where do you rank among the 11,000? Come find out at #ESCCongress @CREATION stand E555 (Hall8)
Daniel Ghinn retweeted
We tracked the most-mentioned cardiology indications discussed by online HCPs on #ESCCongress day 1, and #HeartFailure came out on top.
Big peer impact from @HanCardiomd and @KardiologieHH drove high HCP engagement
Read more: linkedin.com/feed/update/urn…
🧵 1/4
